NO953569L - Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse - Google Patents

Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse

Info

Publication number
NO953569L
NO953569L NO953569A NO953569A NO953569L NO 953569 L NO953569 L NO 953569L NO 953569 A NO953569 A NO 953569A NO 953569 A NO953569 A NO 953569A NO 953569 L NO953569 L NO 953569L
Authority
NO
Norway
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
substituted ethers
Prior art date
Application number
NO953569A
Other languages
English (en)
Norwegian (no)
Other versions
NO953569D0 (no
Inventor
Thomas D Aicher
Seung Hoon Cheon
Jeffrey Nadelson
William Ronald James Simpson
William Joseph Houlihan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO953569D0 publication Critical patent/NO953569D0/no
Publication of NO953569L publication Critical patent/NO953569L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO953569A 1994-09-13 1995-09-11 Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse NO953569L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30524994A 1994-09-13 1994-09-13

Publications (2)

Publication Number Publication Date
NO953569D0 NO953569D0 (no) 1995-09-11
NO953569L true NO953569L (no) 1996-03-14

Family

ID=23180015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953569A NO953569L (no) 1994-09-13 1995-09-11 Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse

Country Status (26)

Country Link
EP (1) EP0702015B1 (da)
JP (1) JPH08109183A (da)
KR (1) KR960010649A (da)
CN (1) CN1130186A (da)
AT (1) ATE158585T1 (da)
AU (1) AU3055295A (da)
BR (1) BR9504004A (da)
CA (1) CA2157950A1 (da)
CO (1) CO4410332A1 (da)
CZ (1) CZ229595A3 (da)
DE (1) DE69500758T2 (da)
DK (1) DK0702015T3 (da)
ES (1) ES2108550T3 (da)
FI (1) FI954257A7 (da)
GR (1) GR3025405T3 (da)
HU (1) HUT73432A (da)
IL (1) IL115235A0 (da)
MY (1) MY132008A (da)
NO (1) NO953569L (da)
NZ (1) NZ272976A (da)
PE (1) PE50296A1 (da)
PL (1) PL310372A1 (da)
SI (1) SI0702015T1 (da)
SK (1) SK111195A3 (da)
TR (1) TR199501115A2 (da)
ZA (1) ZA957699B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
DE10333935A1 (de) * 2003-07-25 2005-02-24 Aventis Pharma Deutschland Gmbh Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2858321B1 (fr) * 2003-07-28 2006-01-20 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
ES2139633T3 (es) * 1992-08-31 2000-02-16 Sankyo Co Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica.
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
AU668818B2 (en) * 1993-04-07 1996-05-16 Taiho Pharmaceutical Co., Ltd. Thiazolidine derivative and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
SI0702015T1 (en) 1998-02-28
HUT73432A (en) 1996-07-29
DK0702015T3 (da) 1998-01-12
TR199501115A2 (tr) 1996-06-21
DE69500758T2 (de) 1998-02-26
CZ229595A3 (en) 1996-04-17
CN1130186A (zh) 1996-09-04
ATE158585T1 (de) 1997-10-15
CA2157950A1 (en) 1996-03-14
GR3025405T3 (en) 1998-02-27
PE50296A1 (es) 1996-12-05
FI954257A7 (fi) 1996-03-14
NZ272976A (en) 1996-09-25
EP0702015A1 (en) 1996-03-20
SK111195A3 (en) 1997-06-04
HU9502663D0 (en) 1995-11-28
ES2108550T3 (es) 1997-12-16
JPH08109183A (ja) 1996-04-30
AU3055295A (en) 1996-03-28
MY132008A (en) 2007-09-28
CO4410332A1 (es) 1997-01-09
KR960010649A (ko) 1996-04-20
PL310372A1 (en) 1996-03-18
NO953569D0 (no) 1995-09-11
DE69500758D1 (de) 1997-10-30
FI954257A0 (fi) 1995-09-11
ZA957699B (en) 1997-03-13
IL115235A0 (en) 1995-12-31
EP0702015B1 (en) 1997-09-24
BR9504004A (pt) 1996-09-24

Similar Documents

Publication Publication Date Title
NO972261L (no) Hypolipidemiske benzodiazepiner
FI823860A0 (fi) 3-(1-substituerade-4-piperidyl)-1,2-bensisoxazoler, en process foer framstaellning daerav, en farmaceutisk komposition innehaollande dessa och deras anvaendning som laekemedel
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
NO981628L (no) (Metylsulfonyl)fenyl-2-(5H)-furanoner som cox-2 inhibitorer
NO20052159L (no) Substituert (tiazol-2-yl)-amid eller sulfonamid som glykokinase-aktivatorer nyttige ved behandling av type 2 diabetes.
NO20091626L (no) MGLUR5-modulatorer
MW6088A1 (en) Chemical compounds
NO20005411L (no) Antipicornavirusforbindelser, deres fremstilling og anvendelse
FI945975A0 (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
DE3481840D1 (de) 3-(4-piperidinyl)-1,2-benzisothiazole und deren derivate, verfahren zu ihrer herstellung und verwendung als arzneimittel.
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
SE8505488D0 (sv) Isosilybinfri silibinin
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
NO942481L (da)
NO953569L (no) Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
WO2001079167A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
ATE4117T1 (de) Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel.
FI823433A0 (fi) 1-/3-(6-fluor-1,2-benzisoxazol-3-yl)propyl/-4-(substituerade) piperaziner och -piperidiner, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning som laekemedel
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
DE3264543D1 (en) Cyclic sulfenamides, process for their preparation, medicines containing them and preparation of the latter
NO996128L (no) Nye pentaerytrittderivater, deres fremstilling og anvendelse så vel som mellomprodukter for deres syntese
ATE49959T1 (de) Imidazoloncarbonylarylimidazole, methode zur herstellung und verwendung sowie wirksame zusammensetzungen davon.
DE3161400D1 (en) 5-alkyl-3-alkylthiopropionthioates, process for their preparation and their use as pharmaceutical compositions